L
Lorenzo G. Mantovani
Researcher at University of Milan
Publications - 361
Citations - 38356
Lorenzo G. Mantovani is an academic researcher from University of Milan. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 51, co-authored 324 publications receiving 26740 citations. Previous affiliations of Lorenzo G. Mantovani include University of Naples Federico II & University of Milano-Bicocca.
Papers
More filters
Journal ArticleDOI
Healthcare costs associated with hepatocellular carcinoma and the value of care
TL;DR: A population-based study reporting the healthcare costs associated with HCC, based on the Ontario Cancer Registry and linked administrative data, enrolled 2,341 cases of HCC identified in Ontario, Canada between 2002 and 2008 and measured the “direct costs” of care.
Journal ArticleDOI
Captopril in the management of patients after acute myocardial infarctions. A cost effectiveness analysis in Italy
TL;DR: This work focused on the economics of adding captopril administration to standard care in Italy in AMI patients matching the entry criteria of the SAVE study, and the cost effectiveness ratio was explored under different assumptions on the effectiveness and on the cost of the intervention.
Posted ContentDOI
SARS-CoV-2 lethality did not change over time in two Italian Provinces
Maria Elena Flacco,Cecilia Acuti Martellucci,Francesca Bravi,Giustino Parruti,Alfonso Mascitelli,Lorenzo G. Mantovani,Stefania Boccia,Lamberto Manzoli +7 more
TL;DR: In this sample, Sars-CoV-2 case-fatality rate decreased considerably over time, supporting recent claims of a substantial improvement of SARS-Cov-2 clinical management.
Journal ArticleDOI
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
Alexander T. Cohen,Anthony Maraveyas,Jan Beyer-Westendorf,Agnes Y.Y. Lee,Kerstin Folkerts,Khaled Abdelgawwad,Yoriko De Sanctis,Samuel Fatoba,Luke Bamber,Miriam Bach,Lorenzo G. Mantovani,Cosimo Investigators +11 more
Journal ArticleDOI
Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.
Francesca Rossetti,Simona de Portu,Enrica Menditto,Luciana Scalone,Silvia Bustacchini,Claudio Cricelli,Lorenzo G. Mantovani,Lorenzo G. Mantovani +7 more
TL;DR: Assessment of the pharmacoeconomic consequences of amlodipine besylate therapy administered in patients at high risk of restenosis after PTCA in Italy found it reduced mortality, morbidity for coronary reasons and the need of revascularization procedures.